Lotus Pharmaceuticals Inc. (OTCMKTS:LTUS – Get Free Report) saw a significant growth in short interest during the month of June. As of June 30th, there was short interest totaling 316 shares, a growth of ∞ from the June 15th total of 0 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 3,300 shares, the short-interest ratio is presently 0.1 days.
Lotus Pharmaceuticals Price Performance
Shares of LTUS stock opened at $0.00 on Friday. Lotus Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $0.01.
Lotus Pharmaceuticals Company Profile
Lotus Pharmaceuticals, trading under the symbol LTUS on the OTC Market, is a Taiwan-based pharmaceutical company specializing in the research, development, manufacturing and marketing of prescription medications. The company’s core operations encompass both the production of a broad range of generic drugs and the advancement of novel compounds aimed at therapeutic areas such as oncology, central nervous system disorders, cardiovascular diseases and anti-infective treatments.
Lotus Pharmaceuticals offers multiple dosage forms, including tablets, capsules, injectables and sterile preparations, to meet the needs of hospital and retail pharmacy channels.
Featured Stories
- Five stocks we like better than Lotus Pharmaceuticals
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Lotus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lotus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
